Proceedings of the First Conference on the Biological and Clinical Aspects of Thymic Epithelial Tumors held in Würzburg, Germany, April 14-18, 1996
Inhaltsverzeichnis
I. Histological and Immunological Characterization of Thymic Epithelial Tumors and Their Differential Diagnoses. - 1. Classification of Thymic Epithelial Neoplasms. - 2. Thymic Carcinoma. - 3. Thymoma/Thymic Carcinoma: A Distinctive, Unusual Morphologic Entity. - 4. A Clinicopathological Study of Thymomas in Singapore. - 5. Thymoma: A Clinicopathologic Study of 60 Cases. - 6. p53-Alterations in Thymic Epithelial Tumors. - 7. p53 Protein Expression in Thymic Epithelial Tumors. - 8. p53 Overexpression and Thymoma Prognosis. - 9. Metallothionein Expression in Thymomas: A Tumor Marker for Spindle and Squamoid Thymoma Cells. - 10. Cytokeratin (CK) Profile in Thymomas: CK 10 Is a Marker for Cortical Thymomas and CK 20 a Marker for Medullary Thymomas. - 11. Neuroendocrine Differentiation in Thymic Epithelial Tumors: Immunohistochemical Studies. - 12. Microscopic Thymoma and Myasthenia Gravis: A Clinicopathological and Immunohistochemical Study of Two Cases. - 13. Complex and Differential Cytokeratin Profiles in Thymomas and Correlation with Normal Thymus. - 14. Unusual Recurrence of Mixed Thymoma in Breast. - 15. Histiocytosis -X of the Thymus: Development of Myelomonocytic Leukemia 5 Years after Thymectomy. - II. Altered T Cell Functions in Thymic Epithelial Tumors. - 16. T Cell Development in the Human Thymus. - 17. Intrathymic Autoantigens and Their Role in the Shaping of the Autoimmune T Lymphocyte Repertoire. - 18. T Cell Epitopes of the Acetylcholine Receptor and the Pathogenesis of Myasthenia Gravis. - 19. Thymus in Thymoma-Associated Myasthenia Gravis: Transplantation of Thymoma and Extrathymomal Thymic Tissue into SCID Mice. - 20. Thymic Tumor Progression in SV40T Transgenic Mice Model: Suggestion of Thymoma Thymic Carcinoma Sequence. - 21. Analysis of a Murine Thymic CarcinogenesisModel Induced by the Expression of Large T of SV40. - 22. Inefficient Positive Selection of CD4+ T Cells in Epithelial Cell Tumors of the Human Thymus. - 23. Abnormal T Lymphocyte Development in Myasthenia Gravis-Associated Thymomas. - 24. Oligoclonal Peripheral T-Cell Lymphocytosis as a Result of Aberrant T-Cell Development in a Cortical Thymoma. - 25. Estrogens Modulate IL-6 Production by Cultured Normal and Pathological Human Thymic Epithelial Cells. - III. Paraneoplastic Autoimmunity. - 26. Thymoma and Autoimmune Neurological Disorders: A Search for Missing Links in Pathogenesis. - 27. T-Cell Derived Mechanisms in the Pathogenesis of Myasthenia Gravis. - 28. Thymomas Express Ryanodine Receptor Epitopes. - 29. Titin Epitope in Thymoma. - 30. Accessory Molecule Expression in Human Thymomas and Thymus. - 31. CD40-Expression in Thymoma. - 32. Myasthenia Gravis with Thymoma and Fas Antigen. - 33. Myasthenia Gravis Patients Have a Cellular Immune Response against Titin. - 34. Tumor Necrosis Factor Gene Polymorphisms in Thymoma and Non-Thymoma Myasthenia Gravis. - IV. Diagnosis and Therapy of Thymic Epithelial Tumors. - 35. Clinical Immunology of Thymic Tumors in Patients with Myasthenia Gravis. - 36. Myasthenia Gravis with Thymoma. - 37. Reproducibility of a Histogenetic Classification of Thymic Epithelial Tumours. - 38. Morphology of Thymic Remnants Removed after Video-Assisted Thoracoscopic Extended Thymectomy in Patients with Thymomatous Myasthenia Gravis. - 39. Core Needle Biopsy of Anterior Mediastinum Masses. - 40. Cyclin-Dependent Kinase 6 (PLSTIRE) Expression in Normal Thymus, Thymomas, and T-Cell Lymphoblastic Lymphoma. - 41. Our Approach in the Preparation for Thymectomy in Myasthenia Gravis. - 42. Onset of Myasthenia Gravis after Thymectomy for Thymoma. - V. Management of Thymectomized Patients. - 43. Aspects of Clinical Preparation of Thymectomy in Myasthenic Cases with or without Thymoma and the Clinico-Biological Follow-up of the Thymectomized Patients. - 44. Long-Term Prognosis of Patients with Thymoma-Associated Myasthenia Gravis. - 45. Thymoma and Myasthenia Gravis: Incidence of Tumor Recurrences in 126 Patients. - 46. Thymoma Prognostic Factors and Outcome. - 47. Management of Thymectomised Myasthenic Patients. - 48. Management of Thymectomized Myasthenic Patients. - 49. Therapeutic Options in Locally Advanced Thymoma. - 50. The Role of Radiotherapy in Treatment of Thymoma. - Authors and Sponsors.